Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Otorhinolaryngology |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942017000200215 |
Resumo: | Abstract Introduction: Inflammatory conditions of the nose and paranasal sinuses are very prevalent in the general population, resulting in marked loss of quality of life in affected patients, as well as significant work, leisure, and social activity losses. These patients require specific and specialized treatment. A wide range of oral medications are available. Objective: The present document is aimed to clarify, for professionals treating patients with inflammatory sinonasal diseases, both specialists and general practitioners, specific oral therapies in noninfectious nasal inflammatory conditions. Methods: The methodology used to create this article included the search for the key words: oral corticosteroids, antihistamines, antileukotrienes, rhinitis, rhinosinusitis in the MEDLINE and EMBASE databases in the last 5 years. Since no relevant article was found for the text on the subject of interest in the last 5 years, the search was extended for another 5 years, and so on, according to the authors’ needs. Results: Relevant literature was found regarding the use of antihistamines, antileukotrienes and oral corticosteroids in these conditions. The Brazilian Academy of Rhinology emphasizes, after extensive discussion by the collegiate, key points in the treatment with these drugs. Conclusion: There is support in the literature for the use of these drugs; however, final considerations about the role of each of them have been made. |
id |
ABORL-F-1_02da6798a0b8e8277e0299beb11364f5 |
---|---|
oai_identifier_str |
oai:scielo:S1808-86942017000200215 |
network_acronym_str |
ABORL-F-1 |
network_name_str |
Brazilian Journal of Otorhinolaryngology |
repository_id_str |
|
spelling |
Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseasesRhinitisRhinosinusitisAntihistaminesGlucocorticoidsLeukotriene antagonistsAbstract Introduction: Inflammatory conditions of the nose and paranasal sinuses are very prevalent in the general population, resulting in marked loss of quality of life in affected patients, as well as significant work, leisure, and social activity losses. These patients require specific and specialized treatment. A wide range of oral medications are available. Objective: The present document is aimed to clarify, for professionals treating patients with inflammatory sinonasal diseases, both specialists and general practitioners, specific oral therapies in noninfectious nasal inflammatory conditions. Methods: The methodology used to create this article included the search for the key words: oral corticosteroids, antihistamines, antileukotrienes, rhinitis, rhinosinusitis in the MEDLINE and EMBASE databases in the last 5 years. Since no relevant article was found for the text on the subject of interest in the last 5 years, the search was extended for another 5 years, and so on, according to the authors’ needs. Results: Relevant literature was found regarding the use of antihistamines, antileukotrienes and oral corticosteroids in these conditions. The Brazilian Academy of Rhinology emphasizes, after extensive discussion by the collegiate, key points in the treatment with these drugs. Conclusion: There is support in the literature for the use of these drugs; however, final considerations about the role of each of them have been made.Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial.2017-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942017000200215Brazilian Journal of Otorhinolaryngology v.83 n.2 2017reponame:Brazilian Journal of Otorhinolaryngologyinstname:Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)instacron:ABORL-CCF10.1016/j.bjorl.2017.01.002info:eu-repo/semantics/openAccessMion,Olavo de GodoyMello Jr,João Ferreira deDutra,Daniel LorenaAndrade,Nilvano Alves deAlmeida,Washington Luiz de CerqueiraAnselmo-Lima,Wilma TeresinhaBalsalobre Filho,Leonardo LopesCastro,Jair de Carvalho eGuimarães,Roberto Eustáquio dos SantosLessa,Marcus MirandaManiglia,Sérgio FabrícioMeireles,Roberto CamposNakanishi,MárcioPignatari,Shirley Shizue NagataRoithmann,RenatoRomano,Fabrizio RicciSantos,Rodrigo de PaulaSantos,Marco César Jorge dosTamashiro,Edwineng2017-05-03T00:00:00Zoai:scielo:S1808-86942017000200215Revistahttp://www.bjorl.org.br/https://old.scielo.br/oai/scielo-oai.phprevista@aborlccf.org.br||revista@aborlccf.org.br1808-86861808-8686opendoar:2017-05-03T00:00Brazilian Journal of Otorhinolaryngology - Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)false |
dc.title.none.fl_str_mv |
Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases |
title |
Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases |
spellingShingle |
Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases Mion,Olavo de Godoy Rhinitis Rhinosinusitis Antihistamines Glucocorticoids Leukotriene antagonists |
title_short |
Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases |
title_full |
Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases |
title_fullStr |
Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases |
title_full_unstemmed |
Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases |
title_sort |
Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases |
author |
Mion,Olavo de Godoy |
author_facet |
Mion,Olavo de Godoy Mello Jr,João Ferreira de Dutra,Daniel Lorena Andrade,Nilvano Alves de Almeida,Washington Luiz de Cerqueira Anselmo-Lima,Wilma Teresinha Balsalobre Filho,Leonardo Lopes Castro,Jair de Carvalho e Guimarães,Roberto Eustáquio dos Santos Lessa,Marcus Miranda Maniglia,Sérgio Fabrício Meireles,Roberto Campos Nakanishi,Márcio Pignatari,Shirley Shizue Nagata Roithmann,Renato Romano,Fabrizio Ricci Santos,Rodrigo de Paula Santos,Marco César Jorge dos Tamashiro,Edwin |
author_role |
author |
author2 |
Mello Jr,João Ferreira de Dutra,Daniel Lorena Andrade,Nilvano Alves de Almeida,Washington Luiz de Cerqueira Anselmo-Lima,Wilma Teresinha Balsalobre Filho,Leonardo Lopes Castro,Jair de Carvalho e Guimarães,Roberto Eustáquio dos Santos Lessa,Marcus Miranda Maniglia,Sérgio Fabrício Meireles,Roberto Campos Nakanishi,Márcio Pignatari,Shirley Shizue Nagata Roithmann,Renato Romano,Fabrizio Ricci Santos,Rodrigo de Paula Santos,Marco César Jorge dos Tamashiro,Edwin |
author2_role |
author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Mion,Olavo de Godoy Mello Jr,João Ferreira de Dutra,Daniel Lorena Andrade,Nilvano Alves de Almeida,Washington Luiz de Cerqueira Anselmo-Lima,Wilma Teresinha Balsalobre Filho,Leonardo Lopes Castro,Jair de Carvalho e Guimarães,Roberto Eustáquio dos Santos Lessa,Marcus Miranda Maniglia,Sérgio Fabrício Meireles,Roberto Campos Nakanishi,Márcio Pignatari,Shirley Shizue Nagata Roithmann,Renato Romano,Fabrizio Ricci Santos,Rodrigo de Paula Santos,Marco César Jorge dos Tamashiro,Edwin |
dc.subject.por.fl_str_mv |
Rhinitis Rhinosinusitis Antihistamines Glucocorticoids Leukotriene antagonists |
topic |
Rhinitis Rhinosinusitis Antihistamines Glucocorticoids Leukotriene antagonists |
description |
Abstract Introduction: Inflammatory conditions of the nose and paranasal sinuses are very prevalent in the general population, resulting in marked loss of quality of life in affected patients, as well as significant work, leisure, and social activity losses. These patients require specific and specialized treatment. A wide range of oral medications are available. Objective: The present document is aimed to clarify, for professionals treating patients with inflammatory sinonasal diseases, both specialists and general practitioners, specific oral therapies in noninfectious nasal inflammatory conditions. Methods: The methodology used to create this article included the search for the key words: oral corticosteroids, antihistamines, antileukotrienes, rhinitis, rhinosinusitis in the MEDLINE and EMBASE databases in the last 5 years. Since no relevant article was found for the text on the subject of interest in the last 5 years, the search was extended for another 5 years, and so on, according to the authors’ needs. Results: Relevant literature was found regarding the use of antihistamines, antileukotrienes and oral corticosteroids in these conditions. The Brazilian Academy of Rhinology emphasizes, after extensive discussion by the collegiate, key points in the treatment with these drugs. Conclusion: There is support in the literature for the use of these drugs; however, final considerations about the role of each of them have been made. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-04-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942017000200215 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942017000200215 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1016/j.bjorl.2017.01.002 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. |
publisher.none.fl_str_mv |
Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. |
dc.source.none.fl_str_mv |
Brazilian Journal of Otorhinolaryngology v.83 n.2 2017 reponame:Brazilian Journal of Otorhinolaryngology instname:Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF) instacron:ABORL-CCF |
instname_str |
Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF) |
instacron_str |
ABORL-CCF |
institution |
ABORL-CCF |
reponame_str |
Brazilian Journal of Otorhinolaryngology |
collection |
Brazilian Journal of Otorhinolaryngology |
repository.name.fl_str_mv |
Brazilian Journal of Otorhinolaryngology - Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF) |
repository.mail.fl_str_mv |
revista@aborlccf.org.br||revista@aborlccf.org.br |
_version_ |
1754575992396972032 |